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Abstract 
Mesoporous silica material type SBA-15 was modified with different amounts of Zn (2 and 4 
wt. %) by incipient wetness impregnation method in ethanol. The parent, Zn-modified and 
quercetin loaded samples, were characterized by XRD, N2 physisorption, TEM, thermal 
gravimetric analysis, UV-Vis and FT-IR spectroscopies and in vitro release of quercetin at pH 
5.5 which is typical of dermal formulations. By this loading method anhydrous quercetin was 
formed on the silica carrier. It was found that the different hydrate forms of quercetin 
(dihydrate, monohydrate, anhydrite) significantly influence the physico-chemical properties 
of the delivery system. It was found that hydrate forms of quercetin can be differentiated by 
XRD and by FT-IR spectroscopic methods. Thus, by evaluating the interaction of the drug 
with the silica carrier the changes due to its hydration state always have to be taken into 
account. Formation of Zn-quercetin complex was evidenced on zinc modified SBA-15 silica 
by FT-IR spectroscopy. High quercetin loading capacity (over 40 wt. %) could be achieved on 
the parent and Zn-containing SBA-15 samples. The in-vitro release process at pH=5.5 showed 
slower quercetin release from Zn-modified SBA-15 samples compared to the parent one. 
Additionally, the comparative cytotoxic experiments evidenced that quercetin encapsulated in 
Zn-modified silica carriers has superior antineoplastic potential against HUT-29 cells 
compared to free drug. Zn-modified SBA-15 silica particles could be promising carriers for 
dermal delivery of quercetin. 
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Introduction 
The tremendous interest in the recent years towards elaboration of mesoporous silica 
materials as potential carriers for drugs is based on the advantages of these materials, such as 
biocompatibility, high specific surface and pore volume, tunable pore size, controlled particle 
size and morphology and possibility for surface functionalization [1-7]. In the preparation of 
mesoporous silica nanoparticulate systems a feasible approach is to circumvent the problems 
associated with poor aqueous solubility, low bioavailability and chemical stability of the 
loaded substance. SBA-15 is one of the most common types of mesoporous nanoparticle, and 
its large, hexagonally arrayed pores are capable of ensuring the access of large drug 
molecules. The appropriate surface modification of the silica matrix with metal ions can 
optimize the loading efficacy and the release kinetic of the drug [1,4,5].  
In the recent years natural flavonoids have attracted research interest due to their pleiotropic 
therapeutic potential. Quercetin (2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-
one) is one of the most common flavonols present in nature, a strong antioxidant and a major 
dietary flavonoid. The primary dietary sources of quercetin include onions, apples, wine, 
berries and tea [8-11]. 
 
Scheme 1 Molecular structure of quercetin 
It has been extensively studied because of its broad-spectrum pharmacological activities. 
Quercetin is known to exhibit anticancer, antiviral, antimutagenic and lipid peroxidation 
inhibitory effects. Initially these effects have been attributed to the strong antioxidant 
properties of quercetin, because of its ability to scavenge free radicals and the influence on the 
intracellular redox status. The antioxidant action appears to be a combination of reaction with 
free radicals, inhibition of xanthine oxidation and lipid peroxidation [12-14] and metal ion 
complexation [15]. A vast number of data have unambiguously shown that quercetin is 
endowed by prominent anticancer activity, mediated by pleiotropic actions on malignant cell 
signaling pathways. It was found that quercetin can regulate cell cycle by modulating several 
molecular targets, including p21, cyclin B, p27, and topoisomerase [16]. In addition, quercetin 
displays specific inhibitory effects in various groups of kinases, including Janus kinases 
(JAK) and especially JAK-3 kinase, which is a non-receptor tyrosine kinase predominantly 
expressed in hematopoietic cells [17]. Abnormal activation of JAK-kinase is attributed to 
human hematological malignancies including the orphan-disease cutaneous T-cell lymphoma 
(CTCL) [18]. 
Unfortunately, the clinical realization of quercetin’s therapeutic potential is greatly hampered 
due to unfavorable physicochemical and pharmacokinetic properties. Quercetin is 
characterized with very low aqueous solubility and chemical instability, which respond in low 
bioavailability. To overcome these unfavorable characteristics of the drug a possible approach 
is the elaboration of carriers for optimized oral, systemic, site-specific or topical delivery of 
quercetin. Quercetin has been formulated in liposomes [19], nanoparticles [20,21], metal ions 
complexes [15]. Being a strong antioxidant quercetin acts mainly by chelating metal ions 
(Fe2+, Fe3+, Cu2+)[8]. On the other hand Zn as a chelating agent can form complexes with 
large numbers of biological active molecules like peptides [22], flavonoids, DNA [23], etc. 
On this ground a novel approach to optimized delivery of quercetin or its analogs is based on 
encapsulation in Zn-modified mesoporous silica material. Moreover, modification with Zn is 
suitable for elaboration of carriers for dermal drug delivery because it is the most abundant 
essential transition element in organisms after Fe and it has proven antibacterial activity. 
Therefore, numerous studies have been devoted to the mechanism of metal ion complexation 
of quercetin, the structure and stability of the formed complexes as well as the effect of 
solvent and media [23-25]. Accordingly, we focus our attention on the development of dual-
component formulations with Zn oxide species and quercetin supported on mesoporous silica 
SBA-15 carrier.  
In the present study the formation of the complexes between quercetin and the silanol groups 
of the parent or Zn modified SBA-15 mesoporous silica was investigated. In vitro release 
profiles of quercetin from the obtained mesoporous silica particles were studied in respect of 
their possible application as dermal formulations against cutaneous T-cell lymphoma. The 
cytotoxic potential of non-loaded and quercetin loaded particles was investigated against two 
types of human cells, including HUT-29 cells as a model of CTCL in vitro.  
 
2. Materials and methods 
2.1. Materials 
PEO20PPO70PEO20 (Pluronic P123) was purchased from BASF. Quercetin (>99.5 %), and 
tetraethyl orthosilicate (TEOS) was provided by Aldrich. 
 
2.2. Synthesis of SBA-15 silica material 
SBA-15 silica was prepared following the method described by Zhao et al. [26]. In brief, 2 g 
of P123 was dissolved in a solution of 60 ml deionized water and 6,18 ml HCl (2M) at 35°C, 
followed by addition of 4 g TEOS. The mixture was stirred at 35°C for 24 h before 
autoclaving in a Teflon bottle at 95°C for 24 h. The solid product was filtered and washed 
three times with deionized water. Calcination for template removal was conducted in air with 
a heating rate of 1°C/min at 550°C for 6 h. 
 
2.3. Functionalization of SBA-15 by Zn 
An incipient wetness impregnation technique with Zn(CH3COO)2∙2H2O was applied for 
loading of 2 or 4 wt. % zinc oxide. In a typical experiment zinc acetate - 20.14 mg or 40.28 
mg for 2 or 4 wt. % zinc, respectively, was dissolved in 1 ml ethanol (99.9%) and 300 mg of 
mesoporous support SBA-15 was added. The functionalization was performed at room 
temperature. Samples were calcined in air at 500°C for 3 hours and designated as SBA-15x 
where x= 2 or 4 wt.% Zn. 
 
2.4. Quercetin loading  
SBA-15 and quercetin in ratio 1:1 were stirred in 1 ml ethanol till the total evaporation of the 
solvent. Then the powdered products were washed 3 times with 5 ml water, and dried at 40°C 
overnight. The quercetin loaded SBA-15 formulation was designated as SBA-15Qu, SBA-
15ZnxQu, where x= 2 and 4 wt.%. 
As reference materials for XRD and FT-IR investigations quercetin dihydrate and anhydrite 
were prepared. Quercetin dihydrate was prepared by recrystallizing the parent quercetin 
material in ethanol than keeping it in controlled humidity atmosphere. Quercetin anhydrite 
was prepared by recrystallizing it in methanol several times than heat treated at 120°C for 2h. 
Hydration state of the reference materials was checked by XRD and by thermogravimetric 
analysis. The FT-IR spectrum of the prepared quercetin dihydrate is identical with that of 
found in Aldrich library of FT-IR spectra.  
 
2.5. Characterization 
X-ray powder diffraction patterns were recorded by a Philips PW 1810/3710 diffractometer 
with Bragg-Brentano parafocusing geometry applying monochromatized CuKα (=0.15418 
nm) radiation (40 kV, 35 mA) and a proportional counter. In situ high temperature XRPD 
measurements were carried out in an HTK-1200 Anton-Paar chamber in air with temperature 
programming. Simulated patterns of quercetin dihydrate and monohydrate were calculated 
based on single crystal data of Cambridge structural database by Mercury 3.8 software 
(dihydrate-Fefbex01, monohydrate- Akijek01), whereas that of quercetin anhydrite was based 
on data of Filip et. al. (Quer3), determined by NMR and powder diffraction measurements 
[27]. 
Nitrogen physisorption measurements were carried out at -196°C using Thermo Scientific 
Surfer automatic volumetric adsorption analyzer. Before the analysis, silica samples were 
outgassed under high vacuum for 2 h at 250°C, whereas drug loaded samples were pretreated 
at 80°C for 3 h [28,29]. The pore-size distributions were calculated from the desorption 
isotherms by the BJH method. 
Diffuse reflectance UV-Vis spectra were measured at ambient by Jasco V-670 UV-Vis 
spectrophotometer equipped with an NV-470 type integrating sphere using BaSO4 reflectance 
standard as reference. 
TEM images were taken using a MORGAGNI 268D TEM (100 kV; W filament; point-
resolution = 0.5 nm). Samples were suspended in a small amount of ethanol and a drop of 
suspension was deposited onto the copper grid covered by carbon supporting film and dried at 
ambient. 
Thermogravimetric measurements were performed with a Setaram TG92 instrument with a 
heating rate of 5°C/min in air flow. 
Attenuated Total Reflection Infrared (ATR-FT-IR) spectra were recorded by means of a 
Varian Scimitar 2000 FT-IR spectrometer equipped with a MCT (mercury-cadmium-tellur) 
detector and a single reflection ATR unit (SPECAC “Golden Gate”) with diamond ATR 
element. In general, 128 scans and 4 cm-1 resolution was applied. For all spectra ATR-
correction was performed (Varian ResPro 4.0 software).  
 
2.6. In-vitro release study 
In-vitro quercetin release study was performed in buffer (pH = 5.5) at 37°C. The drug-loaded 
particles (2 mg) were incubated in 200 ml phosphate buffer with pH=5.5 at 37°C under 
stirring (300 rpm). At appropriate time intervals, 3 ml samples were withdrawn from the 
release medium and analyzed by UV-Vis spectroscopy at a wavelength of 367 nm. The 
concentration of the released quercetin was calculated according to the calibration curves 
prepared in pH=5.5 solution (r>0.9993). 
 
 
 
2.7. Cell lines and culture conditions 
The cell lines HEK-293 (human embryonal kidney cells) and HUT-78 (cutaneous T-cell 
lymphoma - CTCL) were supplied by DSMZ GmbH, Germany. Cells were cultured routinely 
in a controlled environment: 37°C in 5% CO2 humidified atmosphere. All cell lines were 
maintained in RPMI 1640 supplemented with 2 mM L-glutamine and 10% fetal calf serum. 
The cell lines were subcultured biweekly to maintain continuous logarithmic growth. 
 
2.8. Cytotoxicity assay 
Cell survival was evaluated by using the standard MTT-dye reduction assay [30] with slight 
modifications [31]. The method is based on the ability of viable cells to metabolize a yellow 
tetrazolium salt to a violet formazan product which is detected spectrophotometrically at 527 
nm. Exponentially growing cells were plated in 96-well sterile plates at a density of 104 cells/ 
well in 100 μL of medium and were incubated for 24 h. Then quercetin and the tested 
mesoporous silica particles were applied for 72 h, using for each concentration a set of 8 
wells. After a 72-h continuous exposure period, 10 μL aliquots from a 5 mg/ml MTT solution 
were added to each well and the plates were further incubated for 4 h at 37°C in a humidified 
5 % CO2 atmosphere. The formazan crystals yielded were solubilized by addition of a 5% 
solution of HCOOH in isopropanol. The MTT-formazan absorbance was read on a 
microprocessor controlled multiplate reader (Labexim LMR-1). The cell survival data were 
normalized as percentage of the untreated control (set as 100% viability) and were fitted to 
sigmoidal dose response curves and the corresponding IC50 values (concentrations causing 
50% suppression of cellular viability) were calculated. 
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Figure 1. XRD patterns of quercetin loaded parent and Zn modified SBA-15 formulations 
compared to pure quercetin 
 
3. Results and Discussion 
3.1. Material characterization 
X-ray powder diffraction pattern of the parent SBA-15 sample at low 2 theta degree region 
confirms the formation of well-ordered 2 D hexagonal mesostructured. For the Zn-modified 
and quercetin loaded silica carriers somewhat decreased intensity and some broadened 
reflections are observed indicating some structural disorder or pore filling. XRD patterns at 
higher angles of quercetin loaded parent and Zn-modified samples (Fig.1) show the presence 
of crystalline quercetin. This is evidence that a part of quercetin can be found on the outer 
surface of the silica nanoparticles or in the voids among the particles. 
Quercetin has three different hydrate forms, namely dihydrate (P-1), monohydrate (P21/c) and 
anhydrous (P21/a) form. The XRD patterns of the three forms were calculated by their single  
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Figure 2. XRD patterns of the parent quercetin dihydrate (A) and the sample recrystallized in 
ethanol (B) recorded at RT, 40, 80, 120°C 
 
crystal data deduced from Cambridge Structural Database, and from the publication of Filip 
et. al. [27]. 
Quercetin can be found in modified SBA-15 samples in its anhydrous form, independently 
whether it contains Zn or not, as experienced also by our former study with SBA-16 and 
MCM-41 support [32]. This is due to the recrystallization process of the drug in ethanol by 
the loading procedure. This was evidenced by recrystallizing the parent quercetin dihydrate in 
ethanol, and then in situ heat treating it at different temperatures up to 120°C (Fig. 2 B). It can 
be seen by the XRD patterns, that anhydrous form is readily crystallizes by the evaporation of 
ethanol at room temperature, and at elevated temperatures only the crystallinity is improved. 
However, direct heat treatment of the parent quercetin dihydrate results in the formation of 
another, not yet identified polymorph of anhydrite (Fig 2 A). Careful investigation of the 
parent quercetin dihydrate reveals that this material is a mixture of real dihydrate and the  
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Figure 3. Nitrogen physisorption isotherms of the parent, Zn functionalized and quercetin-
loaded SBA-15 samples. 
 
unknown polymorph formed at 120°C heat treatment. This unknown polymorph is also 
recrystallizes to anhydrous form upon dissolving in ethanol or in methanol. We found as well, 
that this anhydrous form transforms to mono or dihydrate phase upon longer staying at 
ambient temperature and humidity. According to Srinivas et. al. water solubility of quercetin 
dihydrate and anhydrite is similar up to 80°C [33]. They have found that aqueous solubility of 
anhydrous quercetin varied from 0.00215 g/L at 25°C to 0.665 g/L at 140°C and that of 
quercetin dihydrate varied from 0.00263 g/L at 25°C to 1.49 g/L at 140°C. Thus, hydration 
state does not really influence the bioavailability of quercetin in dermal formulations, but can 
affect its other physical-chemical properties. 
The nitrogen physisorption isotherms of the parent, and quercetin loaded siliceous and Zn-
modified samples are presented in Fig. 3. Textural parameters are summarized in Table 1. The 
isotherms of the samples are of type IV with a H1 type hysteresis loop between 0.6-0.7 
relative pressures, typical for SBA-15 structure. Significant decrease of the textural  
 Figure 4. TEM images of 2 wt% (A), and 4 wt% Zn containing SBA-15 (B) samples. 
 
parameters, such as surface area and total pore volume, of the quercetin loaded samples 
indicate pore filling by quercetin. Taking into account the mass of nitrogen adsorbing silica in 
the drug delivery system, we can calculate the ratio of filled pores by the drug. This amounts 
to 65% for SBA-15Qu sample and about 25% for Zn containing samples. It seems that 
although Zn modification does not result in pore blocking of SBA-15 channels (Table 1) it 
hinders the penetration of quercetin into the channels, probably due to strong interaction of Zn 
with quercetin at the pore entrances. The pore filling by small ZnO nanoparticles (<5 nm) on 
SBA-15Zn2 sample as well as the presence of bigger Zn nanoparticles (around 20 nm) on 
SBA-15Zn4 are shown by TEM images (Fig.4 A and B), and this result is in good accordance 
with the N2 physisorption data. The formation of rod shaped SBA-15 particles with sizes 
around 1-2 µm was confirmed also by TEM investigation. The preservation of mesoporous 
structure after the quercetin deposition on both Zn-containing carriers was approved by TEM 
(not shown).  
Information about the state of Zn in the silica matrix can be obtained by diffuse reflectance 
UV-Vis spectroscopic investigations. Spectra of Zn modified SBA-15 are shown in Fig. 5. On 
Zn modified samples no absorption band at around 350 nm can be observed, assigned to the  
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Figure 5. Diffuse reflectance UV-Vis spectra of Zn-containing SBA-15 samples  
 
Table 1 Textural properties of the studied samples and the quercetin content 
in the parent and Zn-functionalized samples. 
Samples BET (m2/g) Pore volume 
(cm3/g) 
PDa 
(nm) 
Quercetin cont. 
(wt.%) 
SBA-15 870 1.10 6.0 - 
SBA-15Zn2 849 1.06 5.8 - 
SBA-15Zn4 671 0.91 5.9 - 
SBA-15Qu 163  0.23  5.8 41.8 
SBA-15Zn2Qu 260  0.43 5.5 43.7 
SBA-15Zn4Qu 233 0.38 6.0 45.5 
a mean pore diameter calculated by the BJH model. 
 
O2−→Zn2+ ligand to metal charge transfer (LMCT) transition in bulk ZnO phase [34]. 
Nevertheless, absorption bands at 225 and 275 nm are registered. The bands appearing below 
230 nm are associated with the charge transfer transitions of framework zinc species 
coordinated with lattice O2- when metal atoms are incorporated into the silica framework, 
whereas the band around 280 nm can be considered as encapsulated zinc-oxide nanoparticles 
with size of 1-2 nm [34, 35]. It seems that Zn is distributed in SBA-15 in such a way that a 
part of it is incorporated into the silica matrix on the surface of pore walls, however there are 
also small ZnO nanoparticles inside the channels, or on the outer surface of the particles.  
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Figure 6. ATR FT-IR spectra of different quercetin hydrates and quercetin loaded parent (A) 
and Zn modified SBA-15 samples (B). 
 
Compared to MCM-41 and SBA-16 structures [32], SBA-15 represents a transitional state. In 
our former study it was found that by Zn modification mainly ionic Zn species are formed in 
MCM-41. This can be due to the narrower pore size (2.5 nm) and relatively higher amount 
of surface silanol groups of MCM-41. Because of the narrow pore entrances (2.5 nm) in 
SBA-16, small ZnO particles are formed rather on the outer surface of the particles. In SBA-
15 the pores are bigger (6 nm) and there are enough silanol groups on the channel surface for 
Zn to react with, therefore both ionic Zn species and ZnO nanoparticles can be formed, either 
on the outer side or inside the channels. This different distribution of Zn species in the 
different types of silica structures strongly influences their interaction with quercetin as well. 
For clarification of the interaction between quercetin molecule, Zn and the mesoporous silica 
carrier the quercetin loaded samples were characterized by ATR FT-IR method (Fig. 6). 
Parent quercetin shows characteristic IR bands of stretching vibrations of aryl ketonic 
carbonyl (νC=O at 1670-1655 cm-1) and of aromatic ring C=C vibrations (at 1610-1432 cm-1).  
The band at 1350 cm-1 belongs to OH bending vibration of the phenols (likely on carbon 
atoms C3’ and C4’), and the band around 1309 cm-1 can be assigned as in-plane bending 
vibration of aromatic C-H [36-37]. Stretching vibration of C-O bond appears at around 1290 
cm-1. 
Since quercetin can be found in its anhydrous form on SBA-15 carrier, first we have to 
compare the spectra of different quercetin hydrates (Fig. 6 A). The spectra of the dihydrate 
and anhydrite forms show similarities, however, they can be clearly differentiated. In this 
respect, it can be observed that parent quercetin material is a mixture of anhydrite and 
dihydrate form, as evidenced also by XRD measurements. In dihydrate form the carbonyl 
νC=O vibration, due to the hydrogen bonds, can be found at 1655 cm-1, whereas this band is 
shifted to 1670 cm-1 in the anhydrite form. In the aromatic ring C=C vibration region the 
bands in anhydrite form (1616, 1594, 1552, 1511, 1456, and 1430 cm-1) seem to shift to upper 
wavelength (1606, 1558, 1519, 1463 and 1450 cm-1), too. In dihydrate form the δC-OH 
vibration of phenolic groups is shifted to 1380 cm-1 compared to that of in anhydrous 
quercetin at 1350 cm-1. Also the vibrations of aromatic δC-H (1310 cm-1) and νC-O (1288 cm-
1) are more intensive in anhydrite form.  
Observing the spectrum of the SBA-15Qu sample, it rather resembles anhydrous quercetin 
more than the parent one, which is in accordance with XRD investigations. However, the 
intensity decrease of the 1456, 1430 and 1288 cm-1 bands supports that physisorbed quercetin 
interacts with the silanol groups via aromatic rings rather than by phenolic groups. 
FT-IR spectrum of SBA-15 sample modified with 2% of Zn and loaded with quercetin is quite 
similar to that of siliceous SBA-15 (Fig 6 B). However, for the 4 wt.% Zn containing sample 
some changes in the spectrum can be witnessed. The band at 1456 cm-1 related to aromatic  
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Figure 7. TG curves of quercetin loaded parent and Zn modified SBA-15 silica carriers.  
 
C=C vibrations is split (into 1462 and 1448 cm-1, respectively) The band at 1430 cm-1 (related 
to C-H deformation of aromatic A-ring) and that of νC-O vibration at 1288 cm-1 also 
diminished. The main spectral change, however, is the disappearance of the broad, medium 
strong band belonging to OH bending (OH) of phenols at 1350 cm-1. All these changes 
reveal that mainly the aromatic ring (B-ring) of quercetin is affected by the interaction with 
the silica carrier. Since the C ring is fixed, probably the conformation of the quercetin 
molecule also changes (rotation of B-ring along the C-C connecting bond). Taking into 
consideration all the above spectral changes, it seems that the dominant interaction between 
Zn and quercetin occurs through the –OH groups of aromatic B-ring, in contrast to 4% Zn 
modified SBA-16, where the formation of Zn-quercetin complex involves the C=O group and 
the –OH groups of C-ring or A-ring  [32]. 
3.2. Quercetin loading and in vitro release 
Incipient wetness impregnation method was used for quercetin loading into the pores of SBA-
15 and ZnSBA-15 silica carriers. The amount of quercetin in the prepared samples was  
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Figure 8. In-vitro release profiles of quercetin loaded parent and zinc modified SBA-15 
samples at pH=5.5. 
 
investigated by thermogravimetric method (Table 1). TG data (Fig. 7) show high loading of 
quercetin on all samples, it amounts more than 40 %. The similar quercetin loading for Zn-
modified samples (43.7 % for SBA-15Zn2Qu and 45.5 % for SBA-15Zn2Qu) and the initial 
SBA-15 silica (41.6 %) is an indication that textural parameters are not significantly changed 
after the Zn modification (see Table 1).   
In vitro release study of quercetin (Fig. 8) was conducted in phosphate buffer at pH=5.5, 
relevant to the physiological pH of the skin. The parent particles are characterized with initial 
burst effect, as almost 60 % of the drug is released within the first 30 min. In contrast to the 
parent silica, Zn modified samples showed slower quercetin release with no initial burst, 
which is more prominent for SBA-15Zn4 counterparts. However, the complete quercetin 
release was observed within 4 h for all samples. These differences in release profiles of Zn 
modified samples could be attributed to the formation of Zn-quercetin complexes, which are 
temporarily immobilized in the silica structure The formation of water soluble Zn-quercetin 
complexes is also supported by the fact that under the same experimental conditions hardly 
any Zn release is observed from SBA-15Zn2 and SBA-15Zn4 samples. After quercetin 
loading Zn release increased sharply (Table 1) to 65.5 wt.% for SBA-15Zn4Qu and to 100 
wt.% for SBA-15Zn2Qu. This effect can also be associated with the formation of Zn-
quercetin complex, making the metal content of the silica carrier soluble.  
3.3. Cytotoxicity assessment  
The lack of toxicity is an important requirement for all materials used in preparation of drug 
delivery systems. The cytotoxicity potential of mesoporous carriers was determined in two 
human cell lines with different cell types and origin, namely non-malignant HEK-293 and 
malignant HUT-78. The two cell lines were chosen in order to discriminate between the 
growth inhibitory potential of tested systems and free drug against non-tumorigenic and 
malignant cell lines. HEK-293 cells represent non-cancerous epithelial cells, whereas HUT-78 
is a suitable model for cutaneous T-cell lymphoma (CTCL). A characteristic feature of CTCL 
is the constitutive over-activity of JAK-3 kinase, which is selectively inhibited by quercetin, 
making this polyphenol a potential targeted drug for this condition [38]. 
The growth inhibitory concentration-response curves are presented in Fig. 9 and the 
corresponding equieffective IC50 values are summarized in Table 2. The non-loaded silica 
particles failed to induce any significant decrease in cell viability of non-malignant HEK-293 
cell line even at the highest dose of 1 mg/ml (not shown). The cytotoxicity of quercetin loaded 
mesoporous nanoparticles was determined on the same cell lines as empty NPs and compared 
with the effect on cell proliferation of free drug (Fig.8 A and B). As evident from the graphs 
quercetin and its SBA-15 and SBA-15Zn2 formulations did not show inhibitory effect on cell 
proliferation of non-malignant HEK-293 cells. Quercetin loaded SBA-15Zn4 causes 
erradication of app. 49 % of the treated cells, but even at the highest tested concentration IC50 
values were not reached. In contrast, in malignant HUT-78 cells all tested formulations  
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Figure 9. The concentration-response curves determined by the MTT-dye reduction assay 
after 72 hours continuous exposure. Each data point represents the arithmetic mean  SD of 8 
separate experiments. 
 
Table 2 Equieffective concentrations of tested quercetin formulations, vs. the free 
drug. 
Cell line IC50 (M) 
     Quercetin   SBA-15Qu     SBA-15Zn2Qu SBA-15Zn4Qu 
HEK-293 n.d. n.d. n.d. n.d. 
 HUT-78 174.8 95.14 91.3 26.5 
 
exerted clear concentration dependent cytotoxic effects. These findings show that the tested 
quercetin loaded SBA-15 and SBA-15Zn2 formulations are characterized with high 
selectivity against malignant cells and are non-harmful for normal cells. In addition to their 
selectivity quercetin loaded mesoporous silica materials were superior in terms of cytotoxic 
activity as compared to the free quercetin compound. The concentration-response curves were 
shifted to the lower concentrations and respectively the IC50 values were app. two folds lower 
as compared to the effects of quercetin, applied as an ethanol solution. This effect was more 
pronounced in Zn-modified quercetin loaded particles, causing more than 70 % eradication of 
viable cells at the highest concentration 200 M.  
4. Conclusions 
Mesoporous SBA-15 silica was modified with different amounts of Zn (2 or 4 wt.%) by post-
synthesis method. Quercetin was loaded by incipient wetness impregnation method with 
ethanol on the initial and Zn-modified SBA-15 samples by 1:1 ratio. By this loading method 
anhydrous quercetin was formed on the silica carrier. It was found that hydration forms of 
quercetin can be differentiated by XRD and by FT-IR spectroscopic methods. Thus, by 
evaluating the interaction of the drug with the silica carrier the changes due to its hydration 
state always have to be taken into account. It was shown that zinc is incorporated into the 
silica structure and ionic Zn species, as well as oxide nanoparticles encapsulated into the 
channels, or on the outer surface of silica particles are formed. Formation of Zn-quercetin 
complex was evidenced on zinc modified SBA-15 silica by FT-IR spectroscopy. High 
quercetin loading capacity (over 40 wt. %) was registered on the parent and Zn-containing 
SBA-15 samples. The in-vitro release process at pH=5.5 showed slower quercetin release 
from Zn-modified SBA-15 samples compared to the parent one. High quercetin loading and 
controlled release indicate that the obtained delivery systems are promising for dermal 
application. Additionally, the comparative cytotoxic experiments show that quercetin 
encapsulated in Zn-modified silica carrier (2 wt.% Zn) proved to exert superior antineoplastic 
potential against HUT-29 cells compared to free drug. Thus, it can be concluded that Zn-
modified SBA-15 silica particles are promising carriers for dermal delivery of quercetin. 
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